Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

July volatility rocks CapHedge

Wednesday, August 13, 2014

Bailey McCann, Opalesque New York:

Swiss hedge fund Capital Hedge saw its six month positive return streak end in July according to fund performance information obtained by Opalesque. Both the DPI and KAIROS programs posted negative returns for the month of -1.55% and -4.36% respectively. Both programs were hit with end of July volatility, although a managers comment in the document suggests that they are well positioned for July.

CapHedge is an event driven systematic trading firm with two programs. The Downside Protection and Income (DPI) program focuses on short term trades of G10 currencies and options and futures on S&P, Nasdaq and Russel 3000 indexes. Despite it's recent down month, the fund remains in positive territory up 3.3% year to date. Annualized return through July 30 is 10.44%. The fund has approximately $137m in assets under management and has a target capacity of $300m.

The second program, KAIROS targets a rule-based quasi-automated portfolio management strategy with a focus on position sizing and timing of the trades. KAIROS includes a basket of liquid ETFs representing each major asset class. The fund is up 4.4% year to date, and has an annualized return of 12.87%. The vehicle was launched in 2013 and has $40m in assets under management.

The MSCI World which serves a benchmark index for the fund returned 3.4% through the end of July representing a decline of 0.83 for the month. Reflecting the volatility on the last trading day of that ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner